Safety and Tolerability Study of INNO-406 to Treat Chronic Myeloid Leukemia or Acute Lymphocytic Leukemia
IsraelCompletedPHASE1
Conditions
Chronic Myeloid Leukemia · Acute Lymphocytic Leukemia
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Charite University of Medicine, Berlin, Germany
Johann Wolfgang Goethe Universität, Frankfurt am Main, Germany
University of Heidelberg Medical Clinic, Mannheim, Germany
Chaim Sheba Medical Center, Tel Litwinsky, Israel
Study leads
Hagop Kantarjian, M.D.
Principal Investigator
University of Texas, MD Anderson Cancer Center, Houston, TX 713-792-7026 hkantarj@mdanderson.org